Fast immune cells for fluid build-up from cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a treatment using your own immune cells (T cells) to fight cancer that has spread to the lining of the lung and is causing fluid buildup. It may help if other standard treatments have stopped working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have fluid in your chest from cancer that started in the lung lining or from mesothelioma, and standard treatments have stopped helping.
- You are 18 to 79 years old.
- Your heart pumps well (ejection fraction 45% or higher).
- You can breathe comfortably without extra oxygen after the fluid is drained.
- You have a good daily activity level (able to do light work or be up and about).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new therapy using your own immune cells (called TILs) to treat cancer that has spread to the lining of the lungs. The goal is to see if these cells can shrink tumors and help you feel better.
This trial tests a drug called tocilizumab, which is given through the tube that drains fluid from your chest or belly. The goal is to see if it can help control cancer-related fluid buildup and improve symptoms.
This trial tests a new drug called MT027 for people with advanced cancer that has spread to the lining around the lungs (pleura) and caused fluid buildup. The drug targets a marker on cancer cells called B7-H3. It may help control the fluid and the cancer.
This trial tests a new type of immune cell therapy made from donor cells that are trained to target two specific proteins found on mesothelioma tumors. The goal is to see if these cells can safely shrink tumors or slow the disease when given directly into the chest or belly area.
This trial tests a treatment that takes immune cells from your tumor, multiplies them in a lab, and gives them back to you to fight the cancer. It is for people with advanced solid tumors who have tried other treatments or cannot have them.
This trial tests a new immune cell therapy for people with advanced solid tumors of the lung, liver, colon, rectum, or breast. It aims to see if the treatment is safe and can help shrink or control the cancer.
Hear when a new Malignant Pleural Effusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.